Identification of expression profiles and transcription factors during EGFR‐TKI acquired resistance in LUAD

Abstract Lung cancer is one of the most‐common malignant tumors while lung adenocarcinoma (LUAD) serves as the major subtype of lung cancer. The epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are an important choice in LUAD targeted therapies. However, EGFR‐TKI acquired resi...

Full description

Bibliographic Details
Published in:Precision Medical Sciences
Main Authors: Lili Feng, Cenzhu Wang, Jiawen Chen, Chenyue Tao, Liuliu Zhang, Luojing Zhou
Format: Article
Language:English
Published: Wiley 2024-12-01
Subjects:
acquired resistance
EGFR‐TKI
LUAD
single‐cell RNA sequencing
Online Access:https://doi.org/10.1002/prm2.12146

Internet

https://doi.org/10.1002/prm2.12146

Similar Items